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disease but found to have normal or near nOrmal RtWkS 
underwent instrumentation f the left main, left anterior 
descending or circumflex coronary artery for measurement 
of coronary vasodilator reserve using the subselective intra- 
coronary Doppler catheter (Millar Mikro-Tip 20 MHZ DoP- 
pier catheter, model DC-101). Near normal coronary arteries 
were defined as those with 130% luminal diameter narrow- 
ing in a major vessel or a major branch. Informed consent 
was obtained from each patient for the intracoronary DOP- 
pier flow reserve study. All studies were approved by the 
Human Assurance Committee of the Institutional Review 
Board of the Medical College of Georgia. 
of the 68 patients, 50 (74%) had acceptable signals of 
phasic oronary blood flow velocity at baseline study and 
after hyperemic doses of intravenous dipyridamole. TWO 
patients were excluded because they were taking theophyl- 
line. The remaining 48 patients are the subjects of this study. 
Clinical suspicion of coronary artery disease was based 
on a history of chest discomfort, complaints hought to be 
angina1 equivalents, an abnormal rest electrocardiogram 
(ECG) or a stress test suggesting myocardial ischemia. No 
patient had valvular heart disease, pti Jr myocardial infarc- 
tion, asymmetric septal hypertrophy or poor overall medical 
condition. Patients with diabetes mellitus were not excluded. 
Hypertension was defined as repeated blood pressure mea- 
surements >I40190 mm Hg or self-reported taking of antihy- 
pertensive medication. 
Cardiac catheterization a d measurement of coronary 
vasodihbr merve. Coronary angiography and measure- 
ment of coronary vasodilator reserve were p formed in all 
patients. Thirty-seven patients were studied while taking no 
antianginal drugs. Because of clinical indications. two pa- 
tients were studied while receiving a beta-adrenergic blo k- 
ing drug, six a calcium channel blocking drug, two nitrate 
therapy and one triple antianginal drug therapy. Most pa- 
tients received diphenhydramine hydrochloride (50 mg 
orally) as premeditation a d midazolam hydrochloride (0.25 
to 0.5 mg intravenously) for sedation. Left ventricular vol- 
umes and ejection fraction were calculated from the right 
anterior oblique projection using the single plane area-length 
method. Angiography was followed by provocative t sting 
for coronary artery spasm, using up to 0.55 mg of ergonovine 
maleate in divided doses, in 15 patients who had a clinical 
history suggestive of spasm but were not taking calcium 
channel blocking drugs or nitrates at the time of cardiac 
catheterization. 
Before the Doppler phase of the study, heparin (9,000 to 
12,000 U) was infused. The Doppler catheter was placed 
through an 8F angioplasty guiding catheter over a 0.014 
guide wire (Advanced Cardiovascular Systems) placed dis- 
tally in the selected coronary artery; it was then advanced 
into the proximal portion of the selected artery or the distal 
left main artery and range gated into the proximal eft 
anterior descending or circumflex artery. The left anterior 
descending artery was selected most frequently forDoppler 
flow velocity measurements because of its straight akeoff 
from the left main artery and simplicity of ca~~~~atio~. 
each case, the Doppler catheter and the range gate we 
adjusted to obtain an optimal audio signal and phasic tracing 
in the selected coronary artery, and were not changed during 
the study. 
Coronary vasodilator reserve testing was performed by 
measuring flow velocity at baseline and after 0.28 to 0.85 
mg/kg of intravenous dipyridamole (mean dose 0.59 + 0.12 
mg/kg) infused over 4 to 6 min. In general, patients weighing 
z 100 kg received an initial dose of 0.4 mglkg infused over 4 
min, followed by 0.2 mglkg over 2 min if an inadequate 
hyperemic response occurred and clinical status a 
Flow velocity was recorded for at least 2 min after i 
and until a plateau in peak flow reserve occurred. Patients 
weighing < 100 kg received an initial dose of 0.568 mg/kg of 
intravenous dipyridamole over 4 min, followed by an infu- 
sion of 0.28 mglkg, if necessary, as just described. One 
patient could not tolerate this dosage because of severe 
nausea, but demonstrated anadequate flow reserve in re- 
sponse to 0.28 mg/kg of dipyridamole. Six patients received 
the additional hyperemic dose. 
Flow reserve (FR) was calculated as follows: 
FR _ Mean hyperemic coronary flow velocity 
* Mean baseline coronary flow velocity 
Normal flow reserve was defined as a mean coronary flow 
velocity after dipyridamole greater than or equal to three 
times the baseline flow velocity. This value was arrived at on 
the basis ofreports from other laboratories (1,2) and our own 
experience (5). Impaired flow reserve was defined as a ratio 
of <3: 1; markedly impaired serve was defin 
Echocardiographic assessment of ve~tricuI~~ 
Satisfactory two-dimensional echocardiography was per- 
formed in 44 of 48 patients, using either a 2.5 or 3.5 MHz 
phased array transducer linked to an ultrasound system 
(Hewlett-Packard, model 77020-A). Left ventricular hyper- 
trophy was defined as a posterior wall thickness 212 mm 
obtained by a two-dimensional guided M-mode tracing cut 
through the chordae tendineae of the mitral valve apparatus 
in the standard parasternal long-axis image. 
Left ventricular mass was calculated using Troy’s 
method (6), and measurements were made in accordance 
with American Society of Echocardiography criteria (7) as 
follows: 
LV mass (g) = 1.04 [(IVS + LVID t PWT)’ - (LVID)3], 
where LV = left ventricle; IVS = interventricular septal 
thickness in cm; LVID = left ventricular internal dimension 
at end-diastole in cm; and PWT = left ventricular posterior 
wall thickness in cm. The result was then corrected by the 
following equation (8) to correlate with necropsy mass: 
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Age (yr) 
Gender 
Male 
Female 
~ype~ens~o~ 
Diabetes 
Angina pectoris 
Atypical angina 
LVMl (g/m’) 
LVEDP (mm Hg) 
EF 
FW 
LV 
Negative T~al~~~rn 
Perfusi -n Scan 
(n = 32) 
52.5 + 9.4 
9 (28%) 
23 (72%) 
24 (75%) 
6 W?%): 
13 (41%) 
16 (50%) 
113.6 2 24.0: 
19.4 2 8.1 
0.67 t 0.08 
3.5 2 1.3:l(i 
3 of 32 (9%1 
Posilive T~a~~i~rn 
Perfusion Scan 
(n = III 
52.2 2 9.7 
4 (36%) 
7 (64%) 
11 (IW%) 
6 (55%): 
4 (36%) 
6 (55%) 
152.6 2 42.2$ 
18.5 2 8.8 
0.60 c 0.16 
2.2 c 0.8:lI 
3 of 1 I (27%) 
Total Study 
Group 
(n = 48)* 
52.8 2 9.5 
13 (27%) 
35 (73%) 
40 (83%) 
13 (27%) 
18 (38%) 
26 (54%) 
122.6 2 34.2 
18.8 2 8.4 
0.65 -+ 0.1 
3.2 2 1.4:1 
6 of48 (13%) 
ECG = electrocardioglam; Echo = echocardiographic; EF = ejection fraction: FR = 
ventricular hypertrophy: LVMI = left ventricular mass indexed for body surface area. 
LV mass (g) = 0.8 (LV mass) + 0.6. 
Left ventricular mass was indexed by body surface area 
ed in the fasting SkiiC: 
enzation. Thirty-five pa- 
tients were studied while taking no antia~ginal 
cause of clinical indication, two patients were st 
receiving abeta-blocking drug, five a calcium blocking drug 
were 
otocol 
mittee at the Med- 
ical College of Georgia was utilized, Dipyridamole (0.4 
mglkg) was infused intravenously over 4 min, followed by 
treadmill exercise using the modified Bruce protocol. Thal- 
lium-201 (2 mCi) was injected at peak exercise, which was 
continued for 30 to 60 s. acquisition of tbalhum 
images was begun within using standard views (40” 
left anterior oblique, 40” fe ior oblique with 30” caudal 
ang tation, anterior and terior oblique) and a small 
ped with a high resolution 
count5 or 10 min, which- 
ever occurred first. Identical delayed images were acquired 3
to 4 h later. 
Images were interpreted for regional thallium uptake and 
redistribution by two independent observers unaware of 
a~giograpbic and ec 
were resolved by consensus. 
chi-square t st, Fisher’s exact test (two tail) and analysis of 
variance were used to assess tatistical significance, with 
p < 0.05 considered significant. 
obtained using a simple linear model. 
ter 
e I). Clinical charac- 
for the group as a whole (including 4
thallium testing and I patient who had suboptimal testing) 
and for the subgroups of32 patients with a negative and II 
patients with a positive thallium perfusion scan. There were 
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Table 2. Clinical and Test Characteristics of 1 I Patients With Abnormal Dipyridamole or Stress Thallium Tests and Normal or Near 
Normal Coronary Angiograms 
Coronary 
Patient 
No. 
Age WrY 
Gender/Race 
Chest 
Pain HTN DM 
LVEDP 
(mm Hg) 
LVMI 
@/mZI 
Rest 
ECG Perfusion Scan 
Coronary 
Angiography 
Flow 
Reserve 
1 53nwB AP t - IO 236 
2 71/F/B 
3 ‘%/M/B 
4 50/F/W 
5 A ’ ‘>.i/B 
6 49lFIB 
7 43/F/B 
8 58/F/B 
9 68/F/B* 
10 46/F/B 
II 49hmv 
AP 
AA 
AP 
AA 
AA 
AA 
AA 
AA 
AA 
t t 
t t 
t lD+ 
t - 
t ID+ 
t ID+ 
t - 
t ID+ 
t - 
t - 
20 
18 
25 
IO 
20 
36 
I 
29 
14 
I5 
135 
156 
117 
117 
140 
123 
151 
131 
222 
LVH LAD,LCx t 
ST-T PDA t 
NI LAD.LCx t 
LVH LAD,LCx t 
ST-T LAD.LCx.RCA t 
ST-T LCX t 
ST-T LAD.LCx t 
ST-T LAD,LCx t 
LVH LAD,PDA t 
ST-T LCX t 
ST-T PDA t 
Ni 
NI, left 
dominant 
NI 
NI 
Nl 
LI LCX 
NI 
NI 
LI LCX 
Ni 
NI 
I.91 
LAD 
1.8:l 
LCX 
2.841 
LAD 
1.6:1 
LAD 
2.2:1 
LAD 
2.45:l 
LCX 
1.77:1 
LAD 
2.O:I 
LAD 
IS:1 
LAE 
4.3:1 
LAD 
2.0:1 
LAD 
*Stress without dipyridamole thallium test. AA = atypical ngina; AP = angina pectoris; B = black: DM = diabetes mellitus; ECG = electrocardiogram; F 
= female: HTN = hypertension; ID = insulin dependent: LAD = left anterior descending artery; LCx = circumflex artery: LI = luminal irregularities; LVEDP 
= left ventricular end-diastolic pressure: LVH = left ventricular hypertrophy; LVMl = left ventricu’lar mass indexed for body surface area; M = male; N1 = 
normal; PDA = posterior descending coronary artery: RCA = right coronary artery: ST-T = ST and T wave abnormalities. W = white; - = absent; t = present. 
35 women and 13 men with a mean age of 52.8 + 9.5 years. 
Forty patients (83%) had hypertension and 13 (27%) had 
diabetes mellitus. Eighteen presented with classic angina, 26 
with atypical angina and the remainder with an angina1 
equivalent. 
Thallium-201 perfusion scans. Coronary flow reserve was 
significantly ower (p = 0.003) and left ventricular mass 
index was significantly higher (p = 0.0007) in patients with a 
positive versus anegative thallium scan. These findings were 
unchanged when a separate analysis was performed on 
patients who were tested while taking no antianginal drugs. 
Diabetic patients were more common in the positive thallium 
group (p = 0.047). None of the other characteristics listed in 
Table 1 were significantly different between these two 
groups. 
Table 2 summarizes clinical data and test results in the 11 
patients with a positive thallium scan. All 11 were hyperten- 
sive, 9 of 10 with adequate chocardiograms had elevated 
indexed left ventricular wall mass and 6 were diabetic; 10 of 
the 11 had an abnormal baseline ECG. Coronary flow 
reserve was abnormally ow in all nine patients in whom the 
abnormal thallium segment and the angiographic segment in
which flow reserve was measured were concordant. 
Electrocardiography. An abnormal ECG was a common 
finding in our study group, and was present in 34 patients 
(71%). Six patients had ECG evidence of left ventricular 
hypertrophy, five with an associated strain pattern. The 
remaining 28 patients had ST-T wave abnormalities at rest. 
~h~r~iogra~hy. Mean left ventricular posterior wall 
thickness and mass in 
0.21 cm and 122.6 + 34. 
significantly higher in those with a positive than in those with 
a negative thallium scan (152.6 t 42.2 versus 113.6 2 24.0 g; 
p = 0.0007). There was a trend toward an increased indexed 
mass in those with 5. low coronary flow reserve (<3:1) 
compared with those having a normal flow reserve (?3:1), 
but the differences were not statistically significant (129.4 ?
39.6 versus 115.6 2 16.9 g; p = NS). 
Intravenous di~y~~~rno~e-~~rni~d stress t aMium 
tigraphy. Of the 44 stress thallium tests, dipyrid 
exercise was used as the hyperemic agent in 40 cases and 
exercise alone in 4. cases. All four exercise-alone studies 
were maximal or near maximal efforts. The 
pressure product ‘INas not significantly different between 
those with positive and negative thallium scans (25,723 f 
7,720 versus 22,130 2 5,597 beats-min-‘*mm Hg; p = NS). 
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essel M~dergoing invasiv 
of the 48 patients had 
range 3: 1 to 7: I). The 
twenty-four (50%) 
QW reserve, the heart rate 
reserve (12,541 t 3,992 versus 11,581 2 2,999 
hyperemic dose of d 
uz3eive become 
typical normal and 
ies are ~~ese~te~ in 
Figure 1. 
Mean coronary vasodilator reserve for the 48 patients 
was 3.2 2 1.4; it was significantly lower in the group with a 
positive compared with a negative tba~li~rn scan (2.2 + 
versus 3.5 + I .3; p = 0.003) (Fig. 2). Neither left ventric 
mass index nor end-diastolic pressure correlated with coro- 
nary Aow reserve, even after excluding those patients with 
comorbid conditions (diabetes, cardiomyopathy and hy- 
pothyroidism). Coronary flow reserve was, however, lin- 
early related to baseline coronary flow velocity by the 
approximation: y = -0.17~ + 4.59, where the dimensions of
X are in cm/s; r = -0.57; 
serve, 10 had a normal left ventricular indexed mass; none of 
these had a baseline mean flow velocity HI.7 cm/s (see 
representative patient in upper panel of Fig. 1). Thus, we 
used this to define normal baseline flow velocity as 59 cm/s. 
= left anterior dcsc~nding artery: Sys = systdic.= 
Coronary flow reserve i 
atienks with a normal coronary flow reserve 
Coronary Aow reserve ia 32 patients without hallium 
defects (negative scans) and 1 I with thallium defects (positive scans) 
and in 5 patients who did not undergo r complete hallium testing. 
0 
lxx 
l? 0 0 0 
- 
0 
0 0 
0 
0 
Negative Positive 
Thallium Thallium 
Perfusion Perfusion Not Done 
SCaflS scans 
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Baseline Coronary Flow Velocity (cmhec) 
Figure 3. Coronary flow reserve versus baseline coronary flow 
velocity in 48 patients. A correlation was found between the two 
variables such that y = -0.17~ + 4.59; r = -0.57; p = 0.00002. 
Of the 24 patients with abnormal coronary flow reserve, 
four subsets, ofwhich three were hypertensive, were defined 
on the basis of indexed left ventricular mass, baseline flow 
velocity and clinical factors (Table 3).Ten patients in subset 
I had depressed coronary flow reserve, levated indexed left 
ventricular mass due to hypertension a d elevated baseline 
coronary flow velocity. Flow velocity tracings of a typical 
patient are presented in Figure 1 (lower panel). Subset 2 
included six hypertensive patients with depressed coronary 
flow reserve, increased indexed left ventricular mass but 
normal baseline coronary flow velocity. Subset 3 included 
three hypertensive patients with depressed coronary flow 
reserve, normal indexed left ventricular mass but high nor- 
mal to elevated baseline coronary flow velocity. Subset 4 
included three patients who had depressed coronary flow 
reserve, normal indexed left ventricular mass and normal 
baseline coronary flow velocity. This subset inclu 
hypertensive patient with nondilated cardiomyopathy possi- 
bly from alcohol abuse (ejection fraction 41%), a ~o~by~er- 
tensive patient with classic angina and no demonstrable 
cardiac disease and a hypertensive patient who was mark- 
edly hypothyroid. Two patients with low coronary flow 
reserve could not be classified because of poor echocardio- 
graphic windows. 
Abnormal thallium scans were found only in patients with 
increased indexed tricular mass ex for rthe pa- 
tient just describe opathy and 
normal indexed mass (Table 2). Five of IQ patients in subset 
1 and 3 of 6 patients in subset 2h a positive t~a~~,~~m s@an.
Contribution of comortkid co ions. Diabetes mellitus 
was present in 10 (42%) of 24 patients with low coronary flow 
reserve compared with 3 (13%) of 24 patients with normal 
reserve (p = 0.049). Two cases of cardiomyopathy (ejection 
fraction ~50%) and three cases of borderline low systolic 
function (ejection fraction 50% to 55%) were present i  the 
group with depressed flow reserve, but none were found in 
the normal group. There was no signiEcant difference be- 
tween the severity of an abnormal f ow reserve response 
among those with or without diabetes (2.1 f 0.4 versus 2,2 r 
0.5). All diabetic patients also had hypertension. 
Although cardiac catheterization with coronary aogiogra- 
phy continues to be the standard for evaluating chest pain, 
Table 3. Patterns of Coronary Vasodilator Reserve in a Primarily Hypertensive Group With 
Normal or Near Normal Coronary Arteries 
Coronary 
Vasodilator 
Reserve 
Normal coronary vasodI!ator reserve (23: 1) tn = 24)* 
Without LVH 4.2 + 0.7 
(n = 10) 
With LVH 4.2 + 1.1 
(n = 12) 
Ba reline Flow 
Velocity 
(cm& 
4.8 2 2.4 
6.1 2 4.3 
LVMI 
(gld) 
%.I 1? 12.3 
131.6 2 25.7 
Abnormal coronary vasodilator reserve tC3: I) (n = 24): 
With LVH, t flow 2.0 + 0.42 
velocity, HTN 
(a = 10) 
With LVH, nl flow 2.2 2 0.54 
v&city, H-j-;;-’ 
(II = 6) 
Without LVH, t or nl 2.3 + 0.3 
flow velocity, HTN 
tn = 3) 
Miscellaneoust 2.3 k 0.5 
fn = 3) 
14.3 2 2.6 148.8 + 45.4 
5.4 2 2.2 134.9 t 17.0 
11.3 + 3.1 85.9 2 2.5 
7.4 !I 1.5 99.3 + IS.5 
*Included two patients without echocardiographic data. tone patient each with cardiomyopathy, no overt 
cardiac disease and hypothyroidism. LVH = left ventricular hypertrophy (~131 g/m* in men and 2100 g/m* in 
women); nl = normal; t = increased; other abbreviations as in Table 2. 
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s. There was a relatively high inci- 
dence of diabetes among our hypertensive patients. How- 
ever, the presence of diabetes did not appear to worsen the 
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coronary flow reserve abnormalities of hypertensive pa- 
tients. It might be expected that “small vessel” disease due 
to diabetes in the setting of hypertension could cause an 
additive insult o the coronary flow reserve decrement. The 
absence of this finding in our study may be related to the 
small number of diabetic patients or to the complex relation 
between hypertension a d diabetes (23). 
ConeIusIons. Depressed coronary vasodilator reserve isa 
common finding in hypertensive patients with normal or near 
normal coronary arteries referred for cardiac atheterization 
because of suspected atherosclerotic coronary disease. This 
study demonstrates that dipyridamole stress thallium scans 
may be focally positive in hypertensive patients because of a 
depressed coronary flow reserve. In addition, although the 
magnitude of coronary flow reserve decrease isnot linearly 
proportional tothe severity of left ventricular hype -trophy, 
the presence of hypertrophy predicts those hypertensive 
patients who may have a positive thallium scan. 
In a primarily hypertensive tudy group, we found that 
the mechanism of decreased coronary flow reserve was an 
increase in the rest flow velocity secondary to the increased 
metabolic demands of hypertension and left ventricular 
hypertrophy. Using coronary flow reserve, coronary flow 
velocity and indexed left ventricular mass, we were able to 
classify typical and atypical patterns seen in hypertensive 
heart disease. We did not find evidence for an additive ffect 
of diabetes on the coronary flow reserve decrement in 
hypertensive patients, but further study of this is clearly 
necessary. 
Myocardial ischemia may occur in patients with hyper- 
tensive heart disease in the absence of obstructive epicardial 
coronary artery disease. Chronic or recurrent ischemia can 
result in fibrosis, arrhythmias and cardiomyopathy. Thal- 
lium-201 stress perfusion scanning appears to be a promising 
noninvasive marker for this development before the advent 
of classic ECG changes or heart failure. This noninvasive 
approach may identify a subset of patients at risk for 
complications of hypertension, but further study is required 
to determine its role in evaluation ofhypertensive patients. 
__ 
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